Discontinued neuropathic pain therapy between 2009-2015.

about

Assessment of the Target Engagement and D-Serine Biomarker Profiles of the D-Amino Acid Oxidase Inhibitors Sodium Benzoate and PGM030756.Memantine for the treatment of general neuropathic pain: a narrative review.

P2860

Q38638522-6EB7B9B0-288A-4B9C-A80E-3B852B250B0F Q43061597-21BC341D-8CED-463E-BE9A-5028AA3C08EA

P2860

Discontinued neuropathic pain therapy between 2009-2015.

Item

http://www.wikidata.org/entity/Q38608606

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Discontinued neuropathic pain therapy between 2009-2015.

@en

type

Item

label

Discontinued neuropathic pain therapy between 2009-2015.

@en

prefLabel

Discontinued neuropathic pain therapy between 2009-2015.

@en

P1476

Discontinued neuropathic pain therapy between 2009-2015.

@en

P2093

Ivana Knezevic

http://www.w3.org/2001/XMLSchema#string

Kenneth D Candido

http://www.w3.org/2001/XMLSchema#string

Nebojsa Nick Knezevic

http://www.w3.org/2001/XMLSchema#string

Nenad Cicmil

http://www.w3.org/2001/XMLSchema#string

P2860

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

Biological, clinical, and ethical advances of placebo effects.

Anti-TNFα domain antibody construct CEP-37247: Full antibody functionality at half the size.

Pharmacologic management of neuropathic pain: evidence-based recommendations.

Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential

The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection.

Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Neuropathic pain and pharmacological treatment.

Neuropathic pain in the general population: a systematic review of epidemiological studies.

Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder.

P304

1631-1646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2015.1099627

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26472477

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

Discontinued neuropathic pain therapy between 2009-2015.

about

P2860

P2860

Discontinued neuropathic pain therapy between 2009-2015.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921